These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The impact of pharmacist-managed oral anticoagulation therapy in older veterans. Poon IO; Lal L; Brown EN; Braun UK J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786 [TBL] [Abstract][Full Text] [Related]
3. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Witt DM; Sadler MA; Shanahan RL; Mazzoli G; Tillman DJ Chest; 2005 May; 127(5):1515-22. PubMed ID: 15888822 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of oral anticoagulant therapy managed by telephone vs in-office visits in an anticoagulation clinic setting. Wittkowsky AK; Nutescu EA; Blackburn J; Mullins J; Hardman J; Mitchell J; Vats V Chest; 2006 Nov; 130(5):1385-9. PubMed ID: 17099014 [TBL] [Abstract][Full Text] [Related]
5. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting. Agarwal S; Bennett D; Smith DJ Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of a pharmacist-managed anticoagulation service for breast cancer patients. Jones KL; Barnett C; Gauthier M; Boster B; Espirito JL; Michaud LB J Oncol Pharm Pract; 2012 Mar; 18(1):122-7. PubMed ID: 21364079 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the Safety and Effectiveness of Apixaban versus Warfarin in Patients with Severe Renal Impairment. Stanton BE; Barasch NS; Tellor KB Pharmacotherapy; 2017 Apr; 37(4):412-419. PubMed ID: 28117916 [TBL] [Abstract][Full Text] [Related]
8. Discrepancies in identification of major bleeding events in patients taking warfarin. Seto AC; Kenyon K; Wittkowsky AK Pharmacotherapy; 2008 Sep; 28(9):1098-103. PubMed ID: 18752380 [TBL] [Abstract][Full Text] [Related]
9. Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption. Nutescu EA; Bathija S; Sharp LK; Gerber BS; Schumock GT; Fitzgibbon ML Pharmacotherapy; 2011 Dec; 31(12):1161-74. PubMed ID: 22122179 [TBL] [Abstract][Full Text] [Related]
10. Evaluating warfarin management by pharmacists in a community teaching hospital. Chilipko AA; Norwood DK Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419 [TBL] [Abstract][Full Text] [Related]
11. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related]
12. Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacin. Mathews S; Cole J; Ryono RA Pharmacotherapy; 2006 Oct; 26(10):1446-52. PubMed ID: 16999655 [TBL] [Abstract][Full Text] [Related]
13. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department. Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309 [TBL] [Abstract][Full Text] [Related]
14. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol. Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889 [TBL] [Abstract][Full Text] [Related]
15. Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study. Wang SV; Franklin JM; Glynn RJ; Schneeweiss S; Eddings W; Gagne JJ BMJ; 2016 May; 353():i2607. PubMed ID: 27221664 [TBL] [Abstract][Full Text] [Related]
16. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring. Simmons BJ; Jenner KM; Delate T; Clark NP; Kurz D; Witt DM Pharmacotherapy; 2012 Dec; 32(12):1078-84. PubMed ID: 23112110 [TBL] [Abstract][Full Text] [Related]
17. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704 [TBL] [Abstract][Full Text] [Related]
18. Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: a secondary analysis. Abdelhafiz AH; Myint MP; Tayek JA; Wheeldon NM Clin Ther; 2009 Jul; 31(7):1534-9. PubMed ID: 19695402 [TBL] [Abstract][Full Text] [Related]
19. Gains and losses of warfarin therapy as performed in an anticoagulation clinic. Njaastad AM; Abildgaard U; Lassen JF J Intern Med; 2006 Mar; 259(3):296-304. PubMed ID: 16476107 [TBL] [Abstract][Full Text] [Related]
20. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system. Villines TC; Schnee J; Fraeman K; Siu K; Reynolds MW; Collins J; Schwartzman E Thromb Haemost; 2015 Nov; 114(6):1290-8. PubMed ID: 26446456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]